Cargando…
Shmt2: A Stat3 Signaling New Player in Prostate Cancer Energy Metabolism
Prostate cancer (PCa) is a multifactorial disease characterized by the aberrant activity of different regulatory pathways. STAT3 protein mediates some of these pathways and its activation is implicated in the modulation of several metabolic enzymes. A bioinformatic analysis indicated a STAT3 binding...
Autores principales: | Marrocco, Ilaria, Altieri, Fabio, Rubini, Elisabetta, Paglia, Giuliano, Chichiarelli, Silvia, Giamogante, Flavia, Macone, Alberto, Perugia, Giacomo, Magliocca, Fabio Massimo, Gurtner, Aymone, Maras, Bruno, Ragno, Rino, Patsilinakos, Alexandros, Manganaro, Roberto, Eufemi, Margherita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770108/ https://www.ncbi.nlm.nih.gov/pubmed/31500219 http://dx.doi.org/10.3390/cells8091048 |
Ejemplares similares
-
STAT3 Post-Translational Modifications Drive Cellular Signaling Pathways in Prostate Cancer Cells
por: Cocchiola, Rossana, et al.
Publicado: (2019) -
STAT3, a Hub Protein of Cellular Signaling Pathways, Is Triggered by β-Hexaclorocyclohexane
por: Rubini, Elisabetta, et al.
Publicado: (2018) -
Tomato and Olive Bioactive Compounds: A Natural Shield against the Cellular Effects Induced by β-Hexachlorocyclohexane-Activated Signaling Pathways
por: Rubini, Elisabetta, et al.
Publicado: (2021) -
Comparative Analysis of the Interaction between Different Flavonoids and PDIA3
por: Giamogante, Flavia, et al.
Publicado: (2016) -
ERp57/PDIA3: new insight
por: Chichiarelli, Silvia, et al.
Publicado: (2022)